Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management

Immunotherapy is one of the most recent systemic treatments to emerge for use in oncology, and is based on the blocking of inhibitory immune checkpoints to potentiate the immune response to cancer. The anti-cytotoxic T lymphocyte-associated antigen-4 antibody ipilimumab and anti-programmed cell deat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Stucci, Stefania, Palmirotta, Raffaele, Passarelli, Anna, Silvestris, Erica, Argentiero, Antonella, Lanotte, Laura, Acquafredda, Silvana, Todisco, Annalisa, Silvestris, Franco
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5661371/
https://ncbi.nlm.nih.gov/pubmed/29113194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6919
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados